Latest news
Mirum Pharmaceuticals, Inc. Stock 12‑Month Price Target Cut to $138.21, Implies 31% Upside - TradingViewTradingView · Thu, 06 Aug 2026 17:20:21 GMTCitizens Says FDA’s 'Unexpected' Phase 3 Request Clouds Mirum’s Near-Term Outlook – MIRM Stock Crashes 15% - TradingViewTradingView · Thu, 06 Aug 2026 13:46:32 GMTMIRM: Q2 sales surged to $176M, guidance raised, and pipeline advances amid regulatory delays - TradingViewTradingView · Wed, 05 Aug 2026 22:10:51 GMTMirum Pharmaceuticals Q2 sales rise, lifts outlook - TradingViewTradingView · Wed, 05 Aug 2026 20:12:03 GMTMIRM: Q2 2026 sales surged 38% year-over-year, driving higher guidance and pipeline progress - TradingViewTradingView · Wed, 05 Aug 2026 20:10:28 GMTMIRM Q2'26 Earnings: EPS estimate is (0.74) USD - TradingViewTradingView · Tue, 04 Aug 2026 11:00:42 GMTMIRM Q2'26 Earnings: EPS estimate is (0.73) USD - TradingViewTradingView · Wed, 29 Jul 2026 07:00:00 GMT